Becker Business with Scott Becker

Episode: Amazon, Apple, & My Physical Fitness – 10-25-25
Date: October 25, 2025

Overview

In this concise solo episode, Scott Becker draws a playful and insightful parallel between the performance of tech giants Amazon and Apple in the financial markets and his own year in physical fitness. Becker candidly shares personal reflections while also addressing broader trends among both stocks and health and wellness, particularly referencing the impact of GLP-1 drugs (like Ozempic and Wegovy) on fitness trends.

Key Discussion Points & Insights

1. Performance Context: Tech Stocks and Fitness

• The “Magnificent Seven” technology stocks (a group including Microsoft, Google, Meta, Tesla, Amazon, Apple, etc.) have seen a remarkable year overall in the NASDAQ.

• Amazon is up ~2% and Apple is up ~5% year to date, which Becker characterizes as “okay,” but not extraordinary compared to their peers.

  [00:20] Scott Becker: "The Magnificent Seven this year and the Nasdaq this year are overall having a terrific, terrific year. In contrast, Apple is up about 5% and Amazon's up about 2%."

2. Personal Parallel: Fitness Performance

• Becker likens his own fitness journey to the stock performance of Apple and Amazon. While the broader “market” (his peers) is surging—often with the help of GLP-1 weight-loss drugs—his own results are modest by comparison.

• His weight is up about 2%, mirroring Amazon’s 2% growth. He openly shares disappointment in not achieving his desired goals ("wanted it down about 2%").

  [00:40] Scott Becker: "My weight's up about 2%. I really wanted it down about 2%. So that is the similarity to Amazon. We're both up about 2% this year."

3. Trends in Health: The GLP-1 Effect

• Many individuals are seeing tremendous success in their fitness journeys, attributed in part to popular GLP-1 drugs (Ozempic, Wegovy, etc.), likening this trend to the other outperforming tech stocks like Google and Meta.

  [01:10] Scott Becker: "So many people on these GLP1s, this Ozempic, the Novo Nordisk pill, or Shot, the Wegovy, and they seem to be all doing great. So their fitness is surging like the rest of the Magnificent Seven."

• Becker draws a humorous but honest conclusion: while others (and other stocks) are surging, he, Apple, and Amazon are just “doing okay.”

4. Comparative Performances (Statistics Shared)

• Tesla: up 10-12%

• Google: up 33%

• Meta: up 25%

• Microsoft: up 24%

• Becker uses this to juxtapose his year and highlight high performers versus “steady” ones.

  [01:30] Scott Becker: "Even Tesla's up 10–12% now. Google's up 33%. Meta Platforms is up 25%. Microsoft's up 24% or so."

5. Looking Forward: Optimism for the Next Year

• Becker closes with optimism, intent on his own “surge” in the coming year.

  [02:30] Scott Becker: "I am next year going to surge like the rest of the NASDAQ this year. It's not that year."

Notable Quotes & Memorable Moments

• On personal progress:

  "My weight's up about 2%. I really wanted it down about 2%. So that is the similarity to Amazon. We're both up about 2% this year."
  (Scott Becker – 00:40)

• On fitness trends:

  "So many people on these GLP1s, this Ozempic, the Novo Nordisk pill, or Shot, the Wegovy, and they seem to be all doing great. So their fitness is surging like the rest of the Magnificent Seven."
  (Scott Becker – 01:10)

• Hopeful outlook:

  "I am next year going to surge like the rest of the NASDAQ this year. It's not that year."
  (Scott Becker – 02:30)

Timestamps for Important Segments

• 00:00 – Introduction: Theme & Connection among Amazon, Apple, and personal fitness
• 00:20 – Review of NASDAQ and Magnificent Seven stocks’ performance
• 00:40 – Becker’s fitness: Parallels with Amazon’s modest performance
• 01:10 – The GLP-1 phenomenon in wellness and results for others
• 01:30 – Overview of outperforming Magnificent Seven companies
• 02:30 – Closing & Resolution for personal improvement next year

Tone & Style

Scott Becker maintains a self-deprecating, direct, and lighthearted tone, infusing market analogies with personal anecdotes that make the parallel both informative and relatable.

Summary

This short episode is a blend of market intelligence and personal reflection, using the metaphor of stock performance to talk about both business trends and individual health journeys. Becker’s candor about not being a high-flyer this year—alongside Apple and Amazon—offers listeners both humor and perspective, while his acknowledgment of new fitness trends adds a timely business-health crossover. The message closes with optimism and resolve for the future.